Dr. Sebastian Podlipnik

August 2017: Approval of the European Dermatology exam “UEMS – European Board of Dermato-Venereology” in Frankfurt, Germany.

2016 – current: Doctorate in medicine and translational research from the University of Barcelona, ​​Spain.

2013 – 2017: Residency in medical-surgical dermatology and venereology. Hospital Clinic of Barcelona. Distinction of the best resident of the 2017 generation.

2011: Virtual Diploma in Bioethics, Pontificia Universidad Católica de Chile.

2012: Diploma in Research Sciences and Evidence-Based Medicine. University of the Andes, Santiago, Chile

2005-2011: Bachelor of Medicine, Universidad Mayor, Santiago, Chile. Distinction as best student of the 2011 generation

1991- 2004: Sankt Thomas Morus German School, Santiago, Chile.

I specialized in medical-surgical dermatology at the Hospital Clínic in Barcelona and currently I continue working as an assistant in the melanoma unit of this hospital.

I did my doctorate focused on the optimization of monitoring schemes and development of new gene expression profiles in patients with melanoma. Additionally, I am a dermatologist certified by the European Council of Dermatology and Venereology.

My main area of ​​interest in dermatology is skin cancer, surgery and aesthetics. My specific training took place in one of the most renowned dermatological hospitals in Europe. Currently I continue working at the Hospital Clínic in Barcelona along with some of the best dermatologists.

During my career I have written more than 44 articles in high-impact journals in the specialty.

I have made more than 90 communications at different national and international conferences.

I have contributed to the development of more than 10 book chapters.

During 2017 I participated in the teledermatology project in the Sahrawi aid camps.

2018: Winner of the 2018 Clínic MSD Award awarded to the best resident of the 2017 generation of the Hospital Clínic of Barcelona, ​​Spain.

2018: Award for the best cutaneous oncology poster presented during the AEDV 2018 national congress. “Germline mutations in POT1 but not in the TERT promoter are involved in melanoma susceptibility in Spanish families.”

2017: “Eli Lilly Healthcare Provider Restrictive Grant” awarded to attend the European Congress of Dermatology and Venereology organized by the EADV in Geneva, Switzerland. September 2017.

2017: End of residency award 2017 Emili Letang from the Hospital Clínic of Barcelona: “Development and validation of new prognostic biomarkers in melanoma and application in personalized medicine.”

2017: Miguel Armijo Award for the best work published by Spanish authors during 2016, awarded by the Spanish Academy of Dermatology and Venerology, for the work: “Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer ( AJCC) stage IIB, IIC, and III localized primary melanoma: A prospective cohort study”

2014: 2nd Second Prize for the best poster presented during the VI Innovara National Psoriasis Symposium. Sevilla Spain; 2014: “Response to ustekinumab in psoriasis and BMI> 25”.

2012: 2nd place for the best original work published during the year 2012 in the Chilean magazine of dermatology: “Laser tattoo removal in Chile: clinical experience”, Santiago, Chile, 2012.